AAAAAA

   
Results: 1-2 |
Results: 2
Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy
Authors: Coppes, MJ Yanofsky, R Pritchard, S Leclerc, JM Howard, DR Perrotta, M Keays, S Pyesmany, A Dempsey, E Pratt, CB
Citation: Mj. Coppes et al., Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy, J PED H ONC, 21(4), 1999, pp. 274-283
Primary antiphospholipid syndrome with Moyamoya-like vascular changes
Authors: Booth, F Yanofsky, R Ross, IB Lawrence, P Oen, K
Citation: F. Booth et al., Primary antiphospholipid syndrome with Moyamoya-like vascular changes, PED NEUROS, 31(1), 1999, pp. 45-48
Risultati: 1-2 |